PATENT CLAIM ANALYSIS

Application Number: 15976595
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["530", "387300"]

Abstract:
This invention relates to isolated antibodies which recognize the exosite 1 epitope of thrombin and selectively inhibit thrombin without promoting bleeding. These antibody molecules may be useful in the treatment and prevention of thrombosis, embolism and other conditions mediated by thrombin.

Claim (Index 3):
The antibody molecule of  claim 2 , wherein the antibody molecule further binds one or more amino acids selected from the group consisting of: M32, F34, S36a, P37, E39, L40, L65, R67, R75, R77a, I82 and Q151 relative to the amino acid sequence of SEQ ID NO: 1.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.18919
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14309403', '15434639', '15206896', '14363514', '15348250']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7732796452777415
- 35 USC 102 Novelty (BERT): 0.6052836494365817
- Combined Prediction Score: 0.7564800456936256
- Mean Citation Score: 516.9121240000002
- Max Citation Score: 603.5468
- Similarity Product: 452.17603126411433

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test